A novel algorithm to assess risk of heart failure exacerbation using ICD diagnostics: Validation from RAFT

Heart Rhythm

Volumn 11, Issue 9, 2014, Pages 1626-1631

  Gula, Lorne J ^a   Wells, George A ^b   Yee, Raymond ^a   Koehler, Jodi ^c   Sarkar, Shantanu ^c   Sharma, Vinod ^c   Skanes, Allan C ^a   Sapp, John L ^d   Redfearn, Damian P ^e   Manlucu, Jaimie ^a   Tang, Anthony S L ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^c MEDTRONIC INC   (United States)

^d QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^e QUEEN S UNIVERSITY   (Canada)

Author keywords

Algorithm; Diagnosis; Heart failure; Hospital admission; ICD

Indexed keywords

AGED; ALGORITHM; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; FOLLOW UP; HEART FAILURE; HEART RATE; HEART RATE VARIABILITY; HEART RHYTHM; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; CARDIOVASCULAR SYSTEM EXAMINATION; CLINICAL TRIAL; DEVICES; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; RECURRENT DISEASE; REPRODUCIBILITY; STATISTICS AND NUMERICAL DATA; TIME FACTOR;

GLUCOSINOLATE; PROGOITRIN;

AGED; ALGORITHMS; DEFIBRILLATORS, IMPLANTABLE; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; FEMALE; FOLLOW-UP STUDIES; GLUCOSINOLATES; HEART FAILURE; HEART RATE; HOSPITALIZATION; HUMANS; MALE; RECURRENCE; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 84906934843     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2014.05.015     Document Type: Article

References (20)

1. C.W. Yancy, M. Jessup, and B. Bozkurt et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 62 2013 e147 e239
2. W.C. Levy, D. Mozaffarian, and D.T. Linker et al. The Seattle Heart Failure Model: prediction of survival in heart failure Circulation 113 2006 1424 1433
3. G.C. Fonarow, K.F. Adams Jr, W.T. Abraham, C.W. Yancy, and W.J. Boscardin Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis JAMA 293 2005 572 580
4. M.R. Cowie, S. Sarkar, J. Koehler, D.J. Whellan, G.H. Crossley, W.H. Tang, W.T. Abraham, V. Sharma, and M. Santini Development and validation of an integrated diagnostic algorithm derived from parameters monitored in implantable devices for identifying patients at risk for heart failure hospitalization in an ambulatory setting Eur Heart J 34 2013 2472 2480
5. R.S. Small, W. Wickemeyer, R. Germany, B. Hoppe, J. Andrulli, P.A. Brady, M. Labeau, J. Koehler, S. Sarkar, D.A. Hettrick, and W.H. Tang Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert J Card Fail 15 2009 475 481
6. G.B. Perego, M. Landolina, and G. Vergara et al. Implantable CRT device diagnostics identify patients with increased risk for heart failure hospitalization J Interv Card Electrophysiol 23 2008 235 242
7. G.H. Crossley, A. Boyle, H. Vitense, Y. Chang, and R.H. Mead The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts J Am Coll Cardiol 57 2011 1181 1189
8. D.J. Whellan, K.T. Ousdigian, S.M. Al-Khatib, W. Pu, S. Sarkar, C.B. Porter, B.B. Pavri, and C.M. O'Connor Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study J Am Coll Cardiol 55 2010 1803 1810
9. W.T. Abraham, S. Compton, G. Haas, B. Foreman, R.C. Canby, R. Fishel, S. McRae, G.B. Toledo, S. Sarkar, and D.A. Hettrick Intrathoracic impedance vs daily weight monitoring for predicting worsening heart failure events: results of the Fluid Accumulation Status Trial (FAST) Congest Heart Fail 17 2011 51 55
10. V.M. Conraads, L. Tavazzi, M. Santini, F. Oliva, B. Gerritse, C.M. Yu, and M.R. Cowie Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial Eur Heart J 32 2011 2266 2273
11. A.S. Tang, G.A. Wells, and M. Talajic et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure N Engl J Med 363 2010 2385 2395
12. A.S. Tang, G.A. Wells, M. Arnold, S. Connolly, S. Hohnloser, G. Nichol, J. Rouleau, R. Sheldon, and M. Talajic Resynchronization/defibrillation for ambulatory heart failure trial: rationale and trial design Curr Opin Cardiol 24 2009 1 8
13. S. Sarkar, J. Koehler, G.H. Crossley, W.H. Tang, W.T. Abraham, E.N. Warman, and D.J. Whellan Burden of atrial fibrillation and poor rate control detected by continuous monitoring and the risk for heart failure hospitalization Am Heart J 164 2012 616 624
14. P.B. Adamson, A.L. Smith, W.T. Abraham, K.J. Kleckner, R.W. Stadler, A. Shih, and M.M. Rhodes Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device Circulation 110 2004 2389 2394
15. C.M. Yu, L. Wang, E. Chau, R.H. Chan, S.L. Kong, M.O. Tang, J. Christensen, R.W. Stadler, and C.P. Lau Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization Circulation 112 2005 841 848
16. P.J. Lucas, L.C. van der Gaag, and A. Abu-Hanna Bayesian networks in biomedicine and health-care Artif Intell Med 30 2004 201 214
17. A.J. Moss, W. Zareba, W.J. Hall, H. Klein, D.J. Wilber, D.S. Cannom, J.P. Daubert, S.L. Higgins, M.W. Brown, and M.L. Andrews Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883
18. G.H. Bardy, K.L. Lee, and D.B. Mark et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
19. A.S. Tang, H. Ross, C.S. Simpson, L.B. Mitchell, P. Dorian, R. Goeree, B. Hoffmaster, M. Arnold, and M. Talajic Canadian Cardiovascular Society/Canadian Heart Rhythm Society position paper on implantable cardioverter defibrillator use in Canada Can J Cardiol 21 2005 11A 18A
20. Epstein AE, Dimarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008;117:e350-e408.